tiprankstipranks
Resmed (RMD)
NYSE:RMD
Holding RMD?
Track your performance easily

Resmed (RMD) Financial Statements

993 Followers

Resmed Financial Overview

Resmed's market cap is currently ―. The company's EPS TTM is $7.543; its P/E ratio is 31.12; and it has a dividend yield of 0.84%. Resmed is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is $2.32. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.22B$ 1.22B$ 1.16B$ 1.10B$ 1.12B
Gross Profit$ 717.22M$ 715.53M$ 646.93M$ 600.06M$ 617.38M
EBIT$ 383.50M$ 298.42M$ 273.26M$ 272.19M$ 229.59M
EBITDA$ 437.21M$ 353.17M$ 326.63M$ 325.63M$ 284.79M
Net Income Common Stockholders$ 311.36M$ 292.24M$ 231.95M$ 219.42M$ 194.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 426.36M$ 238.36M$ 210.25M$ 209.10M$ 227.89M
Total Assets$ 7.22B$ 6.87B$ 6.91B$ 6.74B$ 6.75B
Total Debt$ 850.24M$ 873.93M$ 1.39B$ 1.50B$ 1.58B
Net Debt$ 423.88M$ 635.57M$ 1.18B$ 1.29B$ 1.35B
Total Liabilities$ 2.03B$ 2.01B$ 2.42B$ 2.49B$ 2.62B
Stockholders Equity$ 5.20B$ 4.86B$ 4.48B$ 4.25B$ 4.13B
Cash Flow-
Free Cash Flow$ 305.93M$ 413.79M$ 248.27M$ 245.42M$ 198.70M
Operating Cash Flow$ 325.54M$ 440.11M$ 272.83M$ 286.28M$ 237.44M
Investing Cash Flow$ 2.15M$ -46.51M$ -41.14M$ -148.98M$ -46.52M
Financing Cash Flow$ -150.76M$ -393.28M$ -238.96M$ -151.13M$ -188.59M
Currency in USD

Resmed Earnings and Revenue History

Resmed Debt to Assets

Resmed Cash Flow

Resmed Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis